Drug · DIN 02091909
LORELCO
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since April 3, 2009; first marketed December 31, 1995.
- Drug Identification Number (DIN)
- 02091909
- Company (DIN owner)
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Probucol C10AX02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PROBUCOL | 250 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 18, 2006: NOC 7974New Drug Submission (NDS) · Manufacturer name change
- September 14, 2000: NOC 1392New Drug Submission (NDS)